Attending #KidneyWk in Philadelphia? Visit Poster 593 today between 10 a.m. and noon to hear more about Prepare-NS. We’re working with the FDA to develop a patient-reported outcomes (PRO) measure for fluid overload in nephrotic syndrome. @dpeipert#kidneydisease#PRO
10 days until the 5K to benefit lung cancer through a fantastic organization, LUNGevity! I'm proud to run the race with this organization because they generate and support research that matter for people with lung cancer. Please donate!
https://t.co/dIMH40iWMB via @DonorDrive
Hello Friends! I'm running the 2023 Life Time Chicago 5K to raise money for lung cancer research. All the money will go to LUNGevity. I'm raising $500 by September 30th for this cause. Please help our team with a contribution!
https://t.co/7F5RVDYT6g
Hot off the press📰
In a paper published yesterday in @NatureMedicine, BRC researchers including @drmelcalvert & @lee_1881, co-leads of our Patient Reported Outcomes research theme, present a new tool they've developed to improve #PPI in health research: https://t.co/0VGyuosseg
A useful paper evaluating the readability of PROMs including SF-36 and PROMIS but misses prior work (e.g., https://t.co/rVjZDa0wDU) showing the importance of item-level estimates. https://t.co/8eGqlbPbTY #Spine#PROMs#HRQOL
FDA COA-CCT workshop Session 1 workshop starts now, moderated by OCE’s @EGHorod with panelists @GitaThanaMD@dpeipert @madeline_pe @srdaniels07 Cheryl Jernigan
You can still register to join: https://t.co/OgwKG69Afi
#OCEOutcomes23
TODAY: Join for the FDA 8th Annual Clinical Outcome Assessment in Cancer Clinical Trials (COA-CCT) Workshop with opening remarks by OCE Deputy Director @pkluetz#OCEOutcomes23
Event details: https://t.co/OgwKG69Afi
Excited to take a listen to @NUFeinbergMed@MSSatNU Chair Emeritus Dr. David Cella describe how to deploy patient reported outcomes measures in @nejmcatalyst https://t.co/Mjh0tTUaaa Dr. Cella is a pioneer and shaped the creation and development of the field of outcome science.